期刊文献+

丁酸钠对Hep-2细胞的生长抑制和诱导凋亡作用及其对端粒酶活性的影响 被引量:2

Effects of sodium butyrate on growth,apoptosis and telomerase activity in Hep-2 cells
原文传递
导出
摘要 目的研究丁酸钠对 Hep-2细胞的生长抑制和诱导凋亡作用及诱导凋亡过程中对端粒酶活性的影响。方法采用四甲基偶氮唑蓝(methyl thiazolyl terazolium,MTT)比色法观察不同浓度丁酸钠对 Hep-2细胞的生长抑制作用,透射电镜下观察其形态学变化,未端脱氧核苷酸转移酶介导的dUTP 缺口末端标记(terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling,TUNEL)法、琼脂糖凝胶电泳和流式细胞仪检测丁酸钠作用后的细胞凋亡情况及细胞周期变化,端粒重复序列扩增(telomeric repeat amplification protocal,TRAP)-银染法检测端粒酶活性变化,RT-PCR 分析端粒酶各组分的 mRNA 表达情况。结果丁酸钠对 Hep-2细胞的生长抑制作用呈时间和剂量依赖性。透射电镜下可见典型的凋亡细胞形态学改变。琼脂糖凝胶电泳可见特征性的凋亡细胞 DNA 梯状条带。TUNEL 法显示,2.5 mmol/L 丁酸钠作用72 h,细胞凋亡指数由作用前的2.27±1.18增加至33.50±2.75。流式细胞仪显示,2.5 mmol/L 丁酸钠作用72h,细胞凋亡率由作用前的2.86%增加至31.28%,G0/G1期细胞比例由50.38%增加至70.88%,S 期细胞比例由 27.40%减少至8.20%,细胞增殖指数由49.62%降低至29.12%。TRAP-银染法显示,丁酸钠作用后细胞端粒酶活性下降,且具有一定时间效应关系。RT-PCR 显示端粒酶逆转录酶表达下降而端粒酶 RNA 模板和端粒酶相关蛋白表达无明显改变。结论丁酸钠对 Hep-2细胞具有生长抑制和诱导凋亡作用,并可能通过下调端粒酶逆转录酶表达而抑制端粒酶活性。 Objective To study the effects of sodium butyrate (SB) on growth, apoptosis and telomerase activity in Hep-2 cells. Methods Growth inhibition effect of SB on Hep-2 cells was assessed by methyl thiazolyl terazolium(MTT) assay. Morphological alterations were observed by electronic microscope. Cell apoptosis was confirmed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) method, DNA fragmentation and flow cytometry (FCM). Cell cycle was analyzed by FCM. Telomerase activity was examined by telomeric repeat amplification protocal (TRAP)-sliver staining. The expression status of telomerase subunits was analyzed by reverse transcription-polymerase chain reaction( RT- PCR). Results A time-and dose-dependent inhibition was detected in cells treated with SB. Typical morphological changes of apoptotic cells were observed under electronic microscop. The characteristic DNA fragmentation of apoptotic cells was detected by agarose gel electrophoresis. Apoptosis and the changes of cell cycle were confirmed by TUNEL method and FCM. The apoptosis indexes of the cells before treatment and at 72 h after SB ( 2. 5 mmol/L) treatment were 2. 27 ± 1.18 and 33.50 ±2. 75 respectively, the apoptosis rates were 2. 86% and 31.28% respectively, the proportion of the cells at G0/G1 stage were 50.38% and 70. 88% respectively, the proportion of the ceils at S stage were 27.40% and 8.20% respectively, and the proliferation indexes of the cells were 49.62% and 29. 12% respectively. Telomerase activity and expression level of human telomerase reverse transcriptase (hTERT), the key subunit of telomerase, decreased after SB treatment. No significant changes were observed in the expression of human telomerase RNA (hTR) and human telomerase associated protein (hTP1), the other two subunit of telomerase. Conclusion SB could inhibit growth of Hep-2 ceils and induce apoptosis in the ceils, and inhibit telomerase activity by decrease expression level of hTERT.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2007年第1期58-63,共6页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
关键词 喉肿瘤 细胞系 脱噬作用 丁酸钠 Laryngeal neoplasms Cell line Apoptosis Sodium butyrate
  • 相关文献

参考文献15

  • 1荣风年,刘薇,汤春生.丁酸钠对子宫内膜癌抑制作用的裸鼠体内实验研究[J].肿瘤防治杂志,2005,12(4):261-263. 被引量:7
  • 2Kuefer R,Hofer MD,Altug V,et al.Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer.Br J Cancer,2004,90:535-541.
  • 3Zhu YZ,Zhu YG,Wang ZJ,et al.Time-dependent apoptotic development and proapoptotic genes expression in rat heart after myocardial infarction.Jpn J Pharmacol,2001,86:355-358.
  • 4潘海乐,段德生,曲波,于维汉.端粒酶、凋亡与肿瘤的关系[J].中华骨科杂志,2000,20(12):747-749. 被引量:2
  • 5Kerr JF,Wvllie AH,Currie AR.Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics.Br J Cancer,1972,26:239-257.
  • 6谭立军,汤雪明.肿瘤领域的细胞凋亡研究[J].生命科学,1995,7(3):3-6. 被引量:20
  • 7Kerr JF,Winterford CM,Harmon BV,et al.Apoptosis:Its significance in cancer and cancer therapy.Cancer,1994,73:2013-2026.
  • 8Norgaard JM,Hokland P.Biology of multiple drug resistance in acute leukemia.Int J Hemat,2000,72:290-297.
  • 9Bearss DJ,Hurley LH,Von Hoff DD.Telomere maintenance mechanisms as a target for drug development.Oncogene,2000,19:6632-6641.
  • 10Lehne G.P-glycoprotein as a drug target in the treatment of multidrug resistant cancer.Curr Drug Targets,2000,1:85-99.

二级参考文献18

  • 1方敏,薛绍白.程序化细胞死亡与肿瘤[J].基础医学与临床,1994,14(3):5-9. 被引量:14
  • 2Takai N, Desmond J C, Kumagai T, et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells[J]. Clin Cancer Res, 2004,10(3): 1141- 1149.
  • 3Yamamoto H, Fujimoto J, Okamoto E, et al. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo[J]. Int J Cancer,1998,76(6) :897-902.
  • 4Kuefer R, Hofer M D, Altug V, et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer[J]. Br J Cancer, 2004, 90(2):535-541.
  • 5Ogawa K, Yasumura S, Atarashi Y, et al. Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells[J]. J Hepatol,2004,40(2) :278-284.
  • 6Chopin V, Toillon R A, Jouy N, et al. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells[J]. Oncogene, 2004, 23(1): 21-29.
  • 7徐萍.端粒酶抑制剂与肿瘤治疗[J].国外医学(肿瘤学分册),1998,25(4):217-219. 被引量:5
  • 8张莉萍,蒋纪恺,谭荣安,刘小珊,张彦,许湘儒,刘北忠,何于娟,康格非.苦参碱对K562细胞株端粒酶活性和细胞周期的影响[J].中华肿瘤杂志,1998,20(5):328-329. 被引量:140
  • 9李夏新,洪平,程少杰.γ射线照射后造血细胞端粒酶活性变化[J].中华放射医学与防护杂志,1998,18(6):377-380. 被引量:13
  • 10刘小珊,娄陵生,蒋纪恺,曾淑蓉,黎学先,唐宗山,康格非.维甲类化合物Ro13-7410对HL-60细胞的作用[J].癌症,1998,17(6):428-430. 被引量:3

共引文献26

同被引文献20

  • 1苟欣,何卫阳,肖明朝,李云祥.SURVIVIN在膀胱癌中的表达及其与癌细胞增殖关系的研究[J].第三军医大学学报,2006,28(4):377-378. 被引量:4
  • 2高岭,董明敏,程秀莲.丁酸钠对Hep-2细胞生长、凋亡及细胞周期的影响[J].郑州大学学报(医学版),2007,42(2):318-322. 被引量:2
  • 3Sanz-Casla MT, Vidaurreta M, Sanchez-Rueda D, et al. Telomerase activity as a prognostic factor in colorectal cancer. Onkologie, 2005, 28 (11): 553-557.
  • 4Lee JH, Khadka P, Baek SH, et al. CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity. J Biol Chem, 2010, 285 (53): 42033-42045.
  • 5Hoshino I, Matsubara H. Recent advances in histone deacetylase targeted cancer therapy. Surg Today, 2010, 40 (9): 809-815.
  • 6Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol, 2002, 147 (2): 197-213.
  • 7Albrechtsson E, Jonsson T, Moller S, et al. Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number. Pancreatology, 2003, 3 (1): 41-46.
  • 8Krishnan AV, Trump DL, Johnson CS, et al. The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am, 2010, 39 (2): 401-418.
  • 9Vails Bautista C, Pinol Felis C, Rene Espinet JM, et al. Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence (Article in English, Spanish). Rev Esp Enferm Dig, 2009, 101 (3): 179-186.
  • 10Gaschott T, Stein J. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection. Recent Results Cancer Res, 2003, 164: 247-257.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部